Previous 10 | Next 10 |
2024-01-08 08:19:00 ET Summary APLT had a considerable run-up since my prior coverage. APLT remains undervalued based on just the galactosemia thesis. However, now the short-term risk has increased considerably, for numerous reasons. AT-001 failed to meet the primary endpoint...
2024-01-05 16:47:44 ET Gainers: Credo Technology Group Holding ( CRDO ) +3% . Gritstone ( GRTS ) +3% . PetMed Express ( PETS ) +3% . Navitas Semiconductor Corporation ( NVTS ) +2% . Intuitive Machines ( LUNR ) +2% . ...
2024-01-05 12:31:54 ET Gainers: Revelstone Capital Acquisition Corp ( RCAC ) +90% . Ainos ( AIMD ) +72% . Banzai International ( BNZI ) +62% . Safe and Green Development ( SGD ) +41% . Swvl Holdings ( SWVL ) +41% . Zoomcar Ho...
2024-01-05 10:00:03 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...
2024-01-05 05:29:04 ET Stock futures inched lower in the early hours of Friday ahead of the December jobs report. Here are some of Friday's biggest stock movers: Biggest stock gainers For further details see: Biggest stock movers today: Peloton, Medical Properties Trust, and...
2024-01-04 18:14:29 ET More on Applied Therapeutics ARISE-HF Phase 3 Trial Likely To Disappoint Due To Multiple Red Flags Applied Therapeutics: Multiple Inflection Points Could Generate Substantial Value Applied Therapeutics: Capital Raise Forthcoming Applied...
AT-001 (caficrestat) demonstrated a strong trend in stabilizing cardiac functional capacity, while the placebo group declined over 15 months AT-001 treatment resulted in a statistically significant difference in cardiac functional capacity in a prespecified subgroup of patients not rece...
2024-01-04 11:37:10 ET Summary Applied Therapeutics has encountered significant valuation challenges since its IPO, primarily due to the limited efficacy of its Aldose Reductase Inhibitors (ARI) franchise. The company is expected to release topline data from ARISE-HF, a phase 3 tr...
2024-01-04 05:19:37 ET Summary EMA validated and accepted the regulatory application of govorestat for the treatment of patients with galactosemia; the FDA has a 60-day review period to look at the application for validation and acceptance. Release of results from the phase 3 ARIS...
2024-01-03 10:55:34 ET More on Applied Therapeutics Applied Therapeutics: Capital Raise Forthcoming Seeking Alpha’s Quant Rating on Applied Therapeutics Historical earnings data for Applied Therapeutics Financial information for Applied Therapeutics ...
News, Short Squeeze, Breakout and More Instantly...
Applied Therapeutics Inc. Company Name:
APLT Stock Symbol:
NASDAQ Market:
Applied Therapeutics Inc. Website:
2024-07-27 17:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that the Company was adde...
2024-06-11 10:45:04 ET Palo Alto Networks Inc (PANW) PANW is trading UP for the last 5 days, and it at trading at $313.28 with volume of 858,188 and a one day change of $4.23 (1.37%). Palo Alto Networks Inc has a 52-week low of 201.17 and a 52-week high of $380.84. The business's 50...